Colloidal Chemistry and Nanostructure Engineering of Gold Nanorods for Glioblastoma Applications Authors: Sofia-Maria Gratsia, Ioannis Maris, Evangelia Tsitsou, Elias Sakellis, Nikos Boukos, Eleni K. Efthimiadou Published: 2025 ABSTRACT This study focuses on the synthesis and characterization of AuNRs optimized for glioblastoma treatment. Using controlled chemical processes, AuNRs with precise size and morphology were synthesized and characterized via dynamic light scattering and transmission electron microscopy. Cytotoxicity assays on glioblastoma (U87MG) and normal (HaCaT) cell lines evaluated their biocompatibility and selective cytotoxicity. Fluorescence microscopy and flow cytometry analyses revealed efficient cellular uptake via endocytosis, supporting their potential for targeted therapy. The results highlight AuNRs as a promising nanoplatform for overcoming key challenges in glioblastoma treatment, including selective tumor targeting and BBB penetration. This research advances precision medicine and underscores the transformative role of nanotechnology in developing next-generation glioblastoma therapies. Introduction Nanotechnology has revolutionized biomedical research by introducing innovative tools for precise diagnosis and effective cancer treatment. Among various nanomaterials, gold nanorods (AuNRs) have garnered significant attention due to their unique physicochemical, optical, and biological properties. Their anisotropic structure endows them with a tunable surface plasmon resonance (SPR), which can be precisely adjusted from the visible to near-infrared (NIR) region by varying their aspect ratio. This tunability allows efficient light absorption and scattering, making AuNRs particularly valuable in bioimaging, photothermal therapy (PTT), and drug delivery applications. − Additionally, their biocompatibility, chemical stability, and ease of surface functionalization make them ideal candidates for targeted and multifunctional nanotherapeutics. Recent studies have emphasized the transformative potential of functionalized gold nanomaterials in cancer theranostics. The work of Fuyuhiko Tamanoi and colleagues in Scientific Reports (2021) demonstrated that functionalized nanosystems can act as high-contrast imaging agents, enhancing visualization of cellular and tissue structures. Furthermore, their development of biodegradable periodic mesoporous organosilica (BPMO) nanomaterials conjugated with imaging moieties highlighted the feasibility of theranostic platforms that integrate diagnostic imaging with localized therapeutic delivery. − These findings underscore the value of nanostructured systems that combine imaging and therapy in a single construct. Building upon these advancements, gold nanorods have recently been explored in various cancer models, including glioblastoma, due to their capacity for NIR-triggered photothermal conversion and tumor-specific targeting. A 2023 study in International Journal of Molecular Sciences compared the photothermal efficiency of AuNRs of different sizes against melanoma and glioblastoma cells, showing that both large and small AuNRs effectively induced apoptosis under NIR irradiation, with larger rods offering enhanced surface functionalization potential. − Similarly, a 2025 report in Materials Horizons described a hybrid nanoplatform combining AuNRs with nanostructured lipid carriers and tumor-targeting peptides (c­(RGDfK)), capable of crossing the blood–brain barrier (BBB) and achieving a remarkable ∼ 78% inhibition of glioblastoma tumor growth with minimal side effects. In another recent advance, Fn14-targeted AuNRs were employed to enhance laser-based thermal therapy for high-grade gliomas, providing precise tumor ablation and improved imaging contrast through computed tomography (CT). , Moreover, gold nanoparticles (AuNPs) have been reported to enhance the immunogenic effects of radiotherapy in glioblastoma by promoting tumor-associated immune activation, suggesting that gold-based nanomaterials may also play a role in immuno-photothermal combination therapies. − Comprehensive reviews, such as the one published in Molecular Cancer (2023), further highlight the expanding role of AuNRs in multimodal cancer therapy, encompassing photothermal, photodynamic, and immunotherapeutic applications. , Glioblastoma multiforme (GBM) remains one of the most aggressive and treatment-resistant forms of brain cancer. Its rapid proliferation, diffuse invasiveness, and strong resistance to chemotherapy and radiotherapy contribute to poor patient prognosis. The blood–brain barrier (BBB) and the persistence of glioblastoma stem cells (GSCs) further complicate effective drug delivery, leading to frequent recurrence and limited treatment efficacy , Despite progress in neurosurgery, radiotherapy, and chemotherapeutic regimens such as Temozolomide, the median survival of GBM patients remains below 15 months. This highlights the urgent need for novel, minimally invasive, and highly targeted nanotherapeutic strategies capable of overcoming biological barriers and enhancing therapeutic precision In this context, AuNRs offer a powerful theranostic platform for glioblastoma management. Their NIR absorption enables localized heating and selective tumor ablation, while their surface can be readily functionalized with targeting ligands, drugs, or biopolymers to enhance tumor selectivity, biocompatibility, and systemic stability. In the present study, AuNRs were synthesized through a controlled seed-mediated growth process, allowing fine-tuning of their aspect ratio and optical properties. The nanorods were characterized by UV–Vis–NIR spectroscopy, dynamic light scattering (DLS), and transmission electron microscopy (TEM) to confirm their structural and optical attributes. Biocompatibility and cytotoxicity were assessed using glioblastoma (U87MG) and normal keratinocyte (HaCaT) cell lines, while cellular uptake was analyzed through fluorescence microscopy and flow cytometry, revealing efficient endocytic internalization. The findings provide a comprehensive foundation for the development of AuNR-based nanotherapeutics that integrate precise imaging and targeted therapy for the treatment of glioblastoma. Experimental Methods Chemicals Hexadecyltrimethylammonium bromide (CTAB, 98%), sodium borohydride (NaBH4, 98%+), and hydrogen tetrachloroaurate (III) trihydrate (HAuCl4, 99.99%) were purchased from Thermoscientific. Silver nitrate (AgNO3, > 99.8%) and l-ascorbic acid (AA, > 99%) were purchased from Fischer Chemicals. Hydrazine hydrate solution (78–82%) was purchased from Sigma – Aldrich and hydroquinone (HQ, 99.5%) was purchased from Acros Organics. Dulbecco’s Modified Eagle Medium (DMEM), Fetal Bovine Serum (FBS), Penicillin-Streptomycin solution 100x, and Dulbecco’s Phosphate Buffered Saline (DPBS) were purchased from BioSera. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and propidium iodide (PI) were purchased from Cayman Chemical. DMSO was obtained from Sigma Life Sciences and RNase A from abmGood. Daunorubicin hydrochloride (DNR) was provided by Pharmacia & Upjohn. High-purity double-distilled H2O, obtained from a Rephile Milli-Q lab water system, was employed in syntheses and relevant characterization methods. Characterization Dynamic Light Scattering (DLS) measurements were carried out using a Malvern Instruments Zetasizer Nano Series equipped with a multipurpose titrator. Each reported value represents the average of three independent measurements, with 20 runs per measurement. Ultraviolet–Visible (UV–vis) absorption spectra were obtained in the wavelength range of 200–600 nm using a Shimadzu UV-2600i spectrophotometer. Transmission Electron Microscopy (TEM) images were acquired on an FEI Talos F200i field-emission (scanning) transmission electron microscope (Thermo Fisher Scientific Inc., Waltham, MA, USA), operating at 200 kV and equipped with a windowless energy-dispersive X-ray spectroscopy (EDS) microanalyzer (6T/100 Bruker, Hamburg, Germany). Photoluminescence (PL) spectra were recorded using a Shimadzu RF-5301PC spectrofluorophotometer over the excitation/emission wavelength range of 300–900 nm. Synthesis of Gold Seed Particles The synthesis of the gold seed particles was performed in an oil bath at 27 °C. First, 5 mL of 200 mM CTAB and 5 mL of 0.5 mM HAuCl4 were added. The mixture was slowly stirred for 5 min. Then, 300 μL of freshly prepared 10 mM NaBH4 was added rapidly. The mixture was subsequently stirred at 1400 rpm for 30 min. By the end of the reaction, the color of the solution had turned brown-red. Synthesis of Gold Nanorods In this study, five different samples were synthesized using the below seed solution. The growth solution varied for each sample, specifically in the type and amount of reducing agent used, while the overall protocol remained consistent. For sample 1, (HQ 2n, when n is the reducing agent concentration), the synthesis was carried out in an oil bath at 40 °C. First, 440 mg of hydroquinone and 50 mL of 50 mM CTAB were added to a round-bottom flask and stirred gently for 1 min. The temperature was then reduced to 30 °C, and 49 mL of 50 mM CTAB along with 20 mL of 1 mM HAuCl4 were added. The mixture was stirred at 400 rpm for 5 min. Finally, 120 μL of seed solution, 2 mL of 10 mM AgNO3, and 30 mL of 1 mM HAuCl4 were introduced, followed by stirring at 800 rpm for 1 h. Upon completion, the solution developed a red-wine color. The same procedure was followed for sample 2, (HQ n/2), except that 110 mg of hydroquinone was used. For the remaining three samples, an additional reducing agent5 μL of ΑΑ (1.05 M)was introduced, and the primary reducing agent was also modified. For sample 3, (HQ-AA), 220 mg of hydroquinone was used. For samples 4 and 5, (Hz-AA 2n) and (Hz-AA n/2), respectively, hydroquinone was replaced with hydrazine (0.702 Μ), using 22 and 11 μL, respectively. All samples exhibited the same red-wine color transition upon completion. − Optical Properties Absorption was collected in a UV–vis Spectrophotometer (UV-2600i, SHIMADZU). Samples were prepared by diluting 200 μL of each one in 800 μL H2O. Pure H2O served as a reference. Fluorescence measurements were performed on an excitation wavelength of 390 to 546 nm and the emitted fluorescence was analyzed at 590 nm. The measurements were performed on a Shimadzu RF-5301PC Spectro fluorophotometer using a 1 cm quartz cell. Colloidal Stability The hydrodynamic diameter (dH) and zeta potential (ζ) of the samples were measured in aqueous suspensions at a concentration of 1 mg/mL using dynamic light scattering (DLS, Malvern Instruments Ltd., Nano-ZS, He–Ne laser 633 nm). The size distribution by %Number intensity and ζ-potential distribution by total counts are shown as the average values from three consecutive measurements, each consisting of 10-s intervals, with 10 and 20 runs, respectively. Morphology Assessment via Electron Microscopy Morphological characterization was performed by transmission electron microscopy (TEM, FEI Talos F200i field-emission transmission electron microscope-Thermo Fisher Scientific Inc., Waltham, MA, USA- operating at 200 kV, equipped with a windowless energy-dispersive spectroscopy microanalyzer -6T/100 Bruker, Hamburg, Germany). Samples were drop-casted on suitable grids. The size distributions of the nanostructures under investigation, as obtained from TEM (dTEM) images, were determined by measuring the diameters of 40–100 individual nanoparticles using ImageJ software. Electrophoresis Gel electrophoresis was used to separate and confirm the presence of different gold nanorod populations based on their size and charge. After loading 10 μL of nanorods into an agarose-based gel matrix, electric field was applied (150 V) causing them to migrate through the pores at different rates. Effective analysis and separation of different nanorod populations were enabled since smaller or charged nanorods travel faster, while the movement of bigger or uncharged populations is hindered. Cell Culture Immortalized cultured human keratinocyte cells (HaCaT) were employed as a model healthy cell line and human derived U87MG cells were studied as the malignant glioma cell line to assess the biocompatibility of the five samples. Cells were cultured in glutamine-enriched DMEM supplemented with 10% v/v heat-inactivated FBS and 1% v/v penicillin/streptomycin at 37 °C in a 5% CO2 atmosphere. Cellular Viability: MTT Assay Cell viability was assessed using the MTT assay. HaCaT (healthy) and U87MG (glioblastoma) cells were seeded in 96-well plates at a density of 1 × 104 cells per well and incubated for 24 h at 37 °C in a humidified 5% CO2 atmosphere to allow cell attachment. The medium was then replaced with fresh medium containing various concentrations of Au samples (1–100 μM). After 24 h of treatment, 10 μL of MTT reagent (5 mg/mL in PBS) was added to each well and incubated for 4 h. The resulting formazan crystals were dissolved in 100 μL of DMSO, and absorbance was measured at 570 nm using a microplate reader. Cell viability (%) was calculated relative to untreated control cells. All experiments were performed in triplicate, and data are presented as mean ± standard deviation. Statistical analysis was conducted using one-way ANOVA with Tukey’s post hoc test, and differences were considered significant at p < 0.05. , In Vitro Fluorescence Microscopy The cellular uptake of 1, 2, 3, 4, and 5 was analyzed with a fluorescence microscope. Images of the five samples were captured using a 1.3MP CMOS Camera (Blue filters: Excitation 410–490 nm, Emission 515 nm – Green filters: Excitation 490–540 nm, Emission 590 nm) attached to the fluorescence microscope (OMAX Trinocular Compound EPI, M834FLR). HaCaT and U87MG cells were cultured on 22 mm coverslips in 6-well culture plates for 24 h. The cells were then incubated with 5 μΜAu of each sample at 37 °C in a 5% CO2 atmosphere for 1 h. After incubation, the cells were washed twice with PBS, fixed with 10% formaldehyde in PBS, washed once again with PBS, and the coverslips were mounted on microscope glass slides for imaging. Flow Cytometry: Cell Cycle Phase Distribution Flow cytometry was conducted to determine cell cycle phases following exposure to the test samples. Cells were cultured in 6-well plates and incubated at 37 °C with 5% CO2 until reaching confluency. Subsequently, culture medium was replaced by DMEM (negative controls), 1 mg/mL DNR dispersed in DMEM (positive controls) and by 50 μΜAu of each sample for the test groups. After 24 h of incubation, cells were harvested by trypsinization, washed with PBS, and fixed with 70% v/v cold ethanol in water for 30 min in the dark at room temperature. Cells were then washed with PBS and incubated for another 30 min in the dark with the staining solution PI/RNase A (50 μg/mL PI and 10 μg/mL RNase A in PBS). Finally, the stained cells were analyzed using a Becton-Dickinson FACS Calibur Flow Cytometer and results were processed on FlowJo Software. Statistical Analysis Biocompatibility assessment results were subjected to two-way ANOVA statistical analysis, with 95% confidence interval, by implementing Tukey’s or multiple comparisons tests. The analyses were performed with GraphPad Prism with significance expressed as ****p ≤ 0.0001, ***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05. Nonsignificant results, with p > 0.05, are not assigned in the graphs. Results and Discussion Morphology and Colloidal Stability Figure displays transmission electron microscopy (TEM) images and corresponding size distribution histograms of five gold nanostructure samples synthesized under varying reducing agent conditions. Each row represents a distinct sample, showcasing differences in particle shape and size uniformity. The first two TEM images depict nanoparticles synthesized with hydroquinone at two concentrations. The particles are predominantly rod-shaped with a relatively high degree of polydispersity. Sample 1 (HQ 2n) exhibits a broader size distribution, as reflected in the right-side histogram with a broad size distribution with a moderate aspect ratio indicating reduced uniformity. Sample 2 (HQ n/2), synthesized with a lower hydroquinone concentration, shows a narrower distribution and more elongated nanorods, suggesting a dependence of aspect ratio on reducing agent quantity. − ΤΕΜ images of HQ (1–3) samples and HZ/AA (4, 5) samples, corresponding to images 1–5 respectively. The corresponding particle length distributions are shown as histograms, illustrating sample-specific size distributions. Sample 3 (HQ-AA) introduces ascorbic acid as a secondary reducing agent alongside hydroquinone. The resulting structures show resulting in longer and more uniform nanorods with a reduced width, indicating a synergistic effect between hydroquinone and ascorbic acid in directing anisotropic growth. The histogram confirms a narrower distribution, implying enhanced uniformity. In Sample 4 (Hz-AA 2n), hydrazine replaces hydroquinone as the primary reducing agent, combined with ascorbic acid. The particles display a notable change in morphology, with shorter, more uniform rods compared to HQ-based samples. The histogram reveals a tight distribution, suggesting improved controlled overgrowth kinetics under these conditions. Sample 5 (Hz-AA n/2), with the further reduced hydrazine amount, results in more isotropic particles including spheroidal and irregular shapes alongside rods. This transition indicates that lower hydrazine levels slow down the reduction process, potentially leading to a mixture of growth pathways. The histogram reflects this increased heterogeneity. All samples exhibit a color shift to red-wine upon synthesis, correlating with the presence of anisotropic nanostructures. The introduction of ascorbic acid consistently improved particle uniformity and growth directionality. Furthermore, switching from hydroquinone to hydrazine significantly influenced shape control, suggesting a critical role of reducing agent strength and kinetics in determining final morphology. In literature, the synthesis of gold nanorods using hydroquinone as a reducing agent often results in minor inconsistencies in shape, with spherical nanoparticles occasionally being formed alongside rod-shaped ones. Similar observations were made in this study; however, the size differs significantly. For samples 1 and 2, the sizes were calculated to be 27 and 51 nm, respectively, with satisfactory distribution, while the literature reports significantly larger nanorods (∼100 nm). Regarding sample 3, the literature presents more accurately rod-shaped nanostructures when equal amounts of ascorbic acid and hydroquinone are used. In contrast, this study demonstrated a range of shapes, from spherical-like nanoparticles to nanorods. Furthermore, the size was calculated to be around 100 nm, double the value reported in the present study (∼47 nm). [21] For samples 4 and 5, the synthetic route is completely novel and, consequently, there are no prior findings for direct comparison. The shape is spherical-like, not rod-shaped as expected, and the size presents widespread distribution, resulting in a suboptimal method for nanorod synthesis. − The size and surface characteristics of the gold nanoparticles were evaluated using both transmission electron microscopy (TEM) and dynamic light scattering (DLS). Table summarizes the TEM-derived particle diameters (dTEM), hydrodynamic diameters (dΗ) from DLS, and zeta potential (ζ) for each sample (Figure S1). 1Nanoparticle Diameter Calculated from TEM (d TEM) and DLS Data of Size (d Η) and Zeta Potential (ζ)sample d TEM (nm) d Η (nm)ζ (mV) 1 27 ± 586.41 ± 23.942 ± 8.9 2 51 ± 582.6 ± 250 ± 5.4 3 47 ± 279.25 ± 24.2733.17 ± 4.24 4 17.5 ± 2.5628 ± 109.93.4 ± 6.56 5 17.5 ± 2.5628 ± 109.91.5 ± 5.12 Nanoparticle Diameter Calculated from TEM (d TEM) and DLS Data of Size (d Η) and Zeta Potential (ζ) For most samples, a clear discrepancy was observed between the physical diameter measured by TEM and the hydrodynamic diameter obtained via DLS. This is expected, as DLS measures the effective diameter of particles including the solvation layer and interactions between the characteristic functional groups of surfactant coatings, while TEM measures the diameter in the solid state. Samples 1 and 3 (HQ 2n and HQ-AA) showed moderate agreement between dTEM and dΗ, indicating well-dispersed particles with limited aggregation. Sample 2 (HQ 1/2n) displayed an unusual inversion, with dΗ (82.6 nm) significantly smaller than dTEM (51 nm), likely due to shape anisotropy underestimation in DLS (Electrophoresis confirms the zeta and size distribution, Figure S1). Samples 4 and 5 (Hz-AA 2n and Hz-AA 1/2n) both exhibited extremely large dΗ values (∼628 nm) despite small dTEM (∼17.5 nm), suggesting inter and intra particle interactions formatting a pseudocluster in suspension. This is supported by their low zeta potential (3.4 mV and 1.5 mV respectively), which indicate poor colloidal stability. High zeta potentials in HQ-based samples (>30 mV) indicate good electrostatic stabilization, correlating with more consistent and smaller dΗ values. In contrast, the Hz-based samples had zeta potential close to zero, indicating minimal repulsive forces and a high tendency to aggregate in aqueous media. − Optical Properties UV–Vis Spectroscopy The UV–vis absorbance spectra of the five gold nanoparticle samples synthesized under different reducing conditions are shown in Figure . Each spectrum displays characteristic features associated with surface plasmon resonance (SPR), influenced by particle shape, size, and aspect ratio. All samples exhibit two main SPR bands. Transverse mode in the 500–550 nm range, corresponding to electron oscillation across the short axis (diameter) of nanorods. A longitudinal mode in the 600–900 nm range, which becomes prominent in anisotropic structures, particularly nanorods, due to electron oscillation along the long axis (length). Samples 1 (black) and 2 (red) both show clear transverse and longitudinal peaks. Specifically, sample 2 displays a strong, red-shifted longitudinal band centered ∼ 780 nm, indicating larger aspect ratio nanorods, consistent with longer or more elongated particles. The higher intensity also suggests higher monodispersity or concentration. Sample 3 (blue) exhibits a broader and less intense longitudinal peak. This implies the presence of nanorods with moderate aspect ratios and possibly some polydispersity. The peak shape suggests a mix of rod lengths or slight deviations in rod uniformity. Sample 4 (green) shows a dominant transverse peak (∼520 nm) and a much less pronounced longitudinal component, suggesting shorter nanorods or more spheroidal particles. This is consistent with lower aspect ratios and TEM observations. In case of sample 5 (magenta), it displays only a weak and broad shoulder with no distinct longitudinal SPR peak. This Indicates predominantly quasi-spherical or highly aggregated particles, in line with their low zeta potential and large DLS diameter (∼628 nm), which suggest poor colloidal stability and aggregation. The synergistic effect of dual reducing agents (HQ/AA, Hz/AA) appears to produce more controlled morphologies, but less elongation compared to single-agent systems. − UV–vis absorption spectra of HQ (1–3) and HZ/AA (4, 5) samples recorded in the range of 400–1000 nm. Distinct absorption features were observed for each formulation, reflecting differences in their electronic structures and interactions. Fluorescence Study by Employing Photoluminescence (PL) Spectroscopy Figure shows the fluorescence emission spectra of gold nanoparticles synthesized with different reducing agents and conditions. Despite gold’s inherently weak fluorescence due to its high electron density and nonradiative relaxation pathways, plasmon-enhanced luminescence can occur, especially in anisotropic nanostructures or under specific surface and size regimes. Photoluminescence (PL) spectra of different samples measured at room temperature. The spectra correspond to 1, 2, and 3 (HQ-based) and 4, 5 (HZ/AA-based) systems, showing distinct emission behaviors across the wavelength range. The peak intensity observed in the 3 sample (blue dashed line) indicates enhanced fluorescence compared to the other systems. Representative TEM images of the corresponding nanostructures are shown next to each spectrum, highlighting the morphological differences that correlate with their optical responses. Sample 1 (black) exhibits the highest fluorescence intensity, with a broad emission peak centered around 440 nm. This is likely due to the presence of rod-like particles with moderate aspect ratio and relatively high surface charge (ζ ≈ +42 mV), which minimizes aggregation and enhances radiative recombination pathways via surface plasmon resonance (SPR) effects. Additionally, sample 3 (blue) shows a sharp, blue-shifted emission peak around 390 nm with the highest intensity among all samples. This can be attributed to the synergistic effect of hydroquinone and ascorbic acid, promoting well-dispersed, moderately anisotropic particles with optimized surface passivation. The sharpness of the peak suggests a narrow size and shape distribution, consistent with earlier TEM and UV–vis findings. Sample 2 (red) presents lower and broader emission, indicating less efficient radiative transitions. This sample showed the most red-shifted SPR peak in UV–vis (∼780 nm), suggesting high aspect ratio nanorods, which often quench fluorescence due to increased nonradiative decay. As for the last two samples, 4 (green) and 5 (purple), they display moderate, nearly flat emission profiles with only slight variation across the spectrum. This is consistent with the high DLS size (∼628 nm) and very low zeta potentials, suggesting significant particle aggregation. Aggregation leads to fluorescence quenching via plasmonic coupling and energy transfer to adjacent particles or the surrounding medium. The observed fluorescence is likely due to interband transitions between the 5d and 6sp bands in gold, enhanced by SPR effects in nanoscale geometries. Surface smoothness, particle dispersion, and aspect ratio play critical roles in modulating emission intensity and wavelength. Samples with high stability (higher absolute ζ values) and moderate anisotropy (e.g., HQ/AA and HQ 2n) promote greater emission, while aggregation (as in Hz-based samples) or extreme anisotropy (HQ n/2) tend to suppress it. , Overall, the distinct emission maxima and intensities observed in this study highlight the influence of synthetic parameters on the optical behavior of gold nanorods. These findings, when compared with established literature, validate the robustness of the synthesis and characterization methods while underscoring the potential of these nanostructures for applications requiring precise photoluminescence properties. Biocompatibility The biocompatibility of the synthesized samples was evaluated by means of the MTT assay on HaCaT (healthy) and U87MG (glioblastoma) cell lines at varying concentrations. In both cell lines (Figure ), cell viability decreased with increasing concentration, dropping to approximately 5% at 100 μMAu. In particular, in case of HaCaT cells, among the different samples, the most promising results are demonstrated in case of 4 since viability reaches approximately 50% after treatment with 50 μΜAu. Satisfactory viability is also observed in case of 5, where toxicity reaches 50% after administration of 10 μMAu. The remaining three samples present lower biocompatibility even above 1 μMAu. This toxicity is probably attributed to the smaller size of the particles, their spherical shape, and, thus, their more efficient internalization in the cells. − MTT assay results showing the effect of different treatments on cell viability in HaCaT (A) and U87MG (B) cell lines. Cells were exposed to increasing concentrations (1–100 μM) of HQ (1–3) and HZ/AA (4, 5) samples. A concentration-dependent reduction in viability was observed, with stronger cytotoxic effects at higher doses. Data are presented as mean ± SD, with statistical significance indicated relative to the control group. In contrast, U87MG cells exhibited significantly reduced viability compared to HaCaT cells. At higher concentrations, hydroquinone-containing samples showed viability below 10%, while hydrazine-containing samples maintained around 40%. At lower concentrations, U87MG cell viability ranged from 30–40%, significantly lower than the corresponding HaCaT values (∼60%) (Figure ). These findings align with the literature, where cell viability consistently decreases at higher nanoparticle concentrations, irrespective of the synthesis method. Additionally, U87MG cells often show greater resilience to synthetic gold nanorods compared to other cell lines. Notably, nanorods generally induce lower cell viability than alternative shapes, such as spheres or stars. Fluorescence Microscopy in Cells The biocompatibility of the five samples was also examined through fluorescence microscopy. In both cell lines, cellular penetration was examined using a fluorescence microscope (OMAX Trinocular Compound EPI, M834FLR model, 10x objective). Fluorescent images of nanorods with samples in the cells are shown in Figure & 6. Cellular uptake in HaCaT cells treated with (A) & (B) 1, (C) & (D) 2, (E) & (F) 3, (G) 4, and (H) 5, scale bar: 100 nm. The presented data indicate that the five tested samples exhibit distinct uptake and localization profile depending on their composition. As shown in Figures and , fluorescence signals were detected in multiple cellular regions, including the cell membrane, cytoplasm (particularly the perinuclear region), and nucleus. Cellular uptake in U87MG cells treated with (A) & (B) 1, (C) 2, (D) 3, (E) 4, and (F) 5, scale bar: 100 nm. In HaCaT cells, fluorescence intensity is extremely strong in the first three samples. Notably, cellular uptake of the 1 sample is so pronounced that the nuclei are clearly visible. Similar uptake patterns are observed in cases 2 and 3. Conversely, in the hydrazine-ascorbic acid (Hz-AA) samples, fluorescence is significantly reduced in both healthy and cancer cells. In particular, the 4 and 5 show no detectable fluorescence in the U87MG cancer cell line. In U87MG cells, treatment with 1 result in intense fluorescence, with clearly visible nuclei. In contrast, samples 2 and 3 exhibit weaker fluorescence signals. These findings align with the fluorescence emission study. Specifically, 1 demonstrated a maximum emission at 420 nm with high intensity and sharp fluorescence peak, indicating strong photoluminescence and efficient cellular penetration in both cell lines. On the other hand, the sample 4 exhibited maximum emission at 470 nm with moderate intensity and broader peak, reflecting moderate fluorescence. Similarly, the sample 5 displayed maximum emission at 430 nm with moderate intensity. As a result, these two samples exhibit weak or undetectable fluorescence in fluorescence microscopy. The findings indicate that cellular uptake and localization of the tested samples are highly dependent on their composition. One demonstrates the most pronounced uptake in both HaCaT and U87MG cells, with fluorescence signals strongly localized in the nucleus, cytoplasm, and membrane. Similarly, 2 and 3 also exhibit significant fluorescence, though at lower intensities. On the contrary, 4 shows minimal to no fluorescence, particularly in U87MG cells, suggesting limited cellular penetration. These results align with the fluorescence emission study, where 1 displayed strong photoluminescence properties. Overall, the data highlights the role of sample composition in determining cellular uptake efficiency and localization patterns, which may have implications for future biomedical applications. It is well-known that gold nanoparticles (AuNPs) can enter cells through several well-studied mechanisms that depend on their size, shape, surface charge, and surface functionalization. In our case, the results indicate that the predominant internalization pathway is active uptake via endocytosis. − Flow Cytometry: Cell Cycle Phase Distribution Gold nanorods selectively disrupt the cell cycle of cancer cells, while sparing healthy cells due to differences in uptake, oxidative stress, and mitotic checkpoint regulation. DNR induces a strong G2/M arrest in both HaCaT and U87MG cells by causing DNA damage and disrupting cell cycle progression. In HaCaT cells, DNR reduces the S-phase population and leads to accumulation in G2/M, reflecting checkpoint activation without extensive cell death. In U87MG glioblastoma cells, DNR causes a more pronounced G2/M arrest and a marked drop in S-phase, consistent with their higher sensitivity to the drug’s cytotoxic and antiproliferative effects. One and 2 induce strong G2/M arrest in U87MG glioblastoma cells, likely leading to apoptosis, while having minimal effects on HaCaT cell line. In contrast, 4 and 5 show little toxicity to either cell type, suggesting surface modifications reduce nanoparticle uptake or stress response (Figure ). Cell cycle phase distribution of HaCaT (left) and U87MG (right) cell lines after treatment with different Au NPs. The percentage of cells in G1 (blue), S (red), and G2/M (green) phases were determined by flow cytometry. In both cell lines, DNR treatment induced a marked G2/M arrest compared to the control. HQ (1–3) and HZ/AA (4, 5) treatments showed varying effects on cell cycle progression, with changes in phase distribution correlating with compound type and concentration. These findings are aligned with previous studies showing that gold nanorods can selectively target cancer cells by interfering with mitotic progression and increasing oxidative damage.1 and 2 may be promising for anticancer applications, while Hz-AA variants could be useful in biocompatible materials. Further studies can be performed to confirm the mechanisms behind this selectivity. − Conclusions This study systematically explores the impact of reducing agent composition on the structural, optical, and biological behavior of gold nanostructures, offering new insights into the synthesis–property–function relationship critical for nanomedicine applications. Through the synthesis of five distinct nanoparticle samples using hydroquinone (HQ), hydrazine (Hz), and ascorbic acid (AA) in varying combinations and concentrations, we demonstrate that the choice and ratio of reductants directly influence particle morphology, dispersion stability, and performance in biological environments. TEM analysis revealed that HQ-based systems favor the formation of anisotropic nanorods, with aspect ratio and polydispersity governed by the reducing agent’s strength and concentration. The addition of AA, particularly in the 3 system, enhanced rod alignment and uniformity, producing structures with higher photoluminescence and more favorable zeta potentials. Optical characterization via UV–vis and PL spectroscopy confirmed that rod-shaped particles exhibit distinct longitudinal surface plasmon resonance bands and enhanced fluorescence, particularly for 1 and 3 samplesfindings consistent with strong surface plasmon resonance (SPR) effects and literature-reported behavior of anisotropic gold nanostructures. In contrast, hydrazine-containing samples (Hz-AA 2n and 1/2n) produced smaller, more isotropic particles with significantly lower zeta potential and larger hydrodynamic diameters, indicative of aggregation and poor colloidal stability. Biocompatibility assays revealed that these nanoparticles were less toxic to healthy cells (HaCaT) while retaining moderate effects on glioblastoma cells (U87MG), likely due to reduced cellular uptake and lower internalization efficiency. Meanwhile, 1 and 2 induced strong cytotoxicity and G2/M arrest in U87MG cells, aligning with their high uptake and fluorescence visibility under microscopy. These findings point to the potential of HQ-based nanorodsespecially those synthesized with optimized AA co-reduction for targeted cancer therapies, owing to their structural uniformity, strong optical signatures, and selective toxicity. Overall, the results contribute to the broader understanding of nanoparticle engineering by showing that reducing agent chemistry is a powerful lever to control gold nanostructure behavior across physical, optical, and biological domains. This framework may guide the development of next-generation plasmonic nanomaterials tailored for diagnostic imaging, photothermal therapy, and drug delivery applications. Supplementary Material